U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season - Merck.com

Read also:

• What would happen if the Soviet Union had simply annexed Manchuria after World War 2 or kept it independent as a puppet state allied them and separate from China as China was too weak too oppose it anyway?
• What is your review of "Regent", episode 5 of Season 2 House of the Dragon?
• Artists get better with age, e.g., painting. Yet when it comes to pop music, the famous work tends to be written when musicians are in their twenties. So, why aren't Bob Dylan or the Stones banging out amazing tunes now?
• Mom Spotted a Growing Bump Near 3-Year-Old Daughter’s Eye. Then Came the Phone Call that Changed Their Lives (Exclusive) - AOL.com
• Can you turn 150 pages into a 5 minute presentation before a meeting?
• President Xi Jinping Speaks with U.S. President Donald J. Trump on the Phone - fmprc.gov.cn
• Final AIDS/LifeCycle Travels Through Santa Barbara County - Noozhawk
• Trump administration’s deep cuts to public health leave system reeling - PBS
• Canadian Robot Finds a Weight Beneath the Ocean Equivalent to 250 Million Elephants - Jason Deegan
• Gene mutation found in the bacterium behind the Black Death helped plague conquer the world, scientists say - CNN